Viewing Study NCT04868604


Ignite Creation Date: 2025-12-24 @ 9:19 PM
Ignite Modification Date: 2026-02-26 @ 4:17 PM
Study NCT ID: NCT04868604
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2021-04-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
Sponsor: Clarity Pharmaceuticals Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module